GSK Plc (GSK)
51.78
-0.63
(-1.20%)
USD |
NYSE |
Aug 24, 16:00
51.79
+0.01
(+0.02%)
Pre-Market: 20:00
GSK EPS Diluted (Quarterly) : 0.2875 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2875 |
| March 31, 2026 | 1.149 |
| December 31, 2025 | 0.414 |
| September 30, 2025 | 1.324 |
| June 30, 2025 | 0.9374 |
| March 31, 2025 | 0.9887 |
| December 31, 2024 | 0.2563 |
| September 30, 2024 | -0.037 |
| June 30, 2024 | 0.7181 |
| March 31, 2024 | 0.6449 |
| December 31, 2023 | 0.2109 |
| September 30, 2023 | 0.9011 |
| June 30, 2023 | 0.9934 |
| March 31, 2023 | 0.8864 |
| December 31, 2022 | 0.8573 |
| September 30, 2022 | 6.227 |
| June 30, 2022 | 0.5173 |
| March 31, 2022 | 1.189 |
| December 31, 2021 | 0.6221 |
| September 30, 2021 | 0.794 |
| June 30, 2021 | 0.9658 |
| March 31, 2021 | 0.7343 |
| December 31, 2020 | 0.4432 |
| September 30, 2020 | 0.797 |
| June 30, 2020 | 1.398 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9978 |
| December 31, 2019 | 0.832 |
| September 30, 2019 | 0.9552 |
| June 30, 2019 | 0.6206 |
| March 31, 2019 | 0.5429 |
| December 31, 2018 | 0.785 |
| September 30, 2018 | 0.9292 |
| June 30, 2018 | 0.3025 |
| March 31, 2018 | 0.3862 |
| December 31, 2017 | -0.3715 |
| September 30, 2017 | 0.8046 |
| June 30, 2017 | -0.1184 |
| March 31, 2017 | 0.6598 |
| December 31, 2016 | 0.1606 |
| September 30, 2016 | 0.5413 |
| June 30, 2016 | -0.3193 |
| March 31, 2016 | 0.2054 |
| December 31, 2015 | -0.2768 |
| September 30, 2015 | 0.4229 |
| June 30, 2015 | 0.1197 |
| March 31, 2015 | 6.284 |
| December 31, 2014 | 0.843 |
| September 30, 2014 | 0.3396 |
| June 30, 2014 | 0.5668 |
| March 31, 2014 | 0.5693 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.9849 |
| Eli Lilly & Co. | 7.939 |
| Merck & Co., Inc. | -0.5405 |
| Pfizer Inc. | -0.0435 |
| Sanofi | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 742.26M |
| Revenue (Quarterly) | 11.29B |
| Total Expenses (Quarterly) | 10.70B |
| Enterprise Value | 124.20B |
| Gross Profit Margin (Quarterly) | 75.05% |
| Profit Margin (Quarterly) | 6.58% |
| Earnings Yield | 6.13% |
| Operating Earnings Yield | 10.54% |
| Normalized Earnings Yield | 8.906 |